SOHO 2023 Eleventh Annual Meeting
A

SOHO 2023: What Is High Risk MCL and How Should We Treat It

By SOHO 2023 Eleventh Annual Meeting FEATURING Anita Kumar
By SOHO 2023 Eleventh Annual Meeting FEATURING Anita Kumar
0 views
October 18, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Recommended

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
25:47
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in Indolent B-Cell Lymphomas

Feat. J. Soumerai
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
25:23
Indy Hematology Review

When Not to Watch and Wait: Emerging Strategies in the Treatment of …

Feat. M. Williams
17:30
SOHO Brazil 2024

Making Sense of 1L Treatment Options in MCL

Feat. T. Phillips
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
04:34
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Feat. P. Jain
18:50
MyCancerHaven

CLL and MCL: Experts Discuss the Use of Pirtobrutinib

Feat. R. Vij, G. Shouse
22:38
Indy Hematology Review

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Feat. T. Phillips
06:43
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…

Feat. V. Yazbeck
15:18
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Practical Updates on Advances in CLL and MCL

Feat. E. Chong
07:22
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…

Feat. A. Ferrajoli
14:34
Northwestern Medicine Oncology and Hematology

EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial

Feat. L. Gordon
05:24
Chan Cheah

Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…